Anneline Cremer

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study

Annick Moens, C. Janneke van der Woude, Mette Julsgaard et al. · Alimentary Pharmacology & Therapeutics · 2019 · 133 citations · Full text

Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy

Uri Kopylov, Jurij Hanžel, Claire Liefferinckx et al. · Alimentary Pharmacology & Therapeutics · 2020 · 78 citations · Full text

Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune‐mediated inflammatory diseases: A European retrospective observational study

Laurent Goessens, Jean‐Frédéric Colombel, An Outtier et al. · United European Gastroenterology Journal · 2021 · 66 citations · Full text

Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia

Anneline Cremer, Pieter Demetter, Martine De Vos et al. · Clinical Gastroenterology and Hepatology · 2019 · 40 citations · Full text

Autoimmune Disease, Immunology, Gastroenterology +8

Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial

Marie Truyens, Triana Lobatón, Marc Ferrante et al. · Gastroenterology · 2022 · 38 citations · Full text

Inflammation, Functional Gastrointestinal Disorder, Gastrointestinal Pharmacology +7